시장보고서

상품코드

1605761

당뇨병 관리 분야 인공지능 시장 : 유형별, 용도별, 전개별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Artificial Intelligence in Diabetes Management Market, By Type, By Application, By Deployment, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

당뇨병 관리 분야 인공지능 시장 규모는 2023년 212억 3,400만 달러로 2024년부터 2032년까지 38.5%의 CAGR로 확대될 것으로 예상됩니다.

당뇨병 관리 분야 인공지능 시장 - 시장 역학

당뇨병 유병률 증가와 AI 기술 발전이 시장 수요를 촉진

세계 당뇨병 환자 증가로 인해 AI 기반 질병 관리 솔루션에 대한 수요가 증가하고 있으며, 2021년 국제당뇨병연맹은 성인 당뇨병 환자가 5억 3700만 명에 달하고 2045년까지 7억 8300만 명에 달할 것으로 예상하고 있습니다. 이러한 급격한 증가로 인해 AI를 활용한 첨단 당뇨병 관리 도구에 대한 필요성이 높아지고 있습니다. 또한, AI와 머신러닝 능력의 향상으로 당뇨병 관리 분야의 AI 시장 성장이 가속화되고 있습니다. 그러나 헬스케어에 AI 시스템을 도입하는 데에는 많은 비용이 소요된다는 점이 걸림돌로 작용하고 있습니다. 반면, 세계 헬스케어 개혁과 정부 이니셔티브는 AI 기반 당뇨병 관리를 지원하여 시장 기회를 촉진하고 있습니다.

당뇨병 관리 분야 인공지능 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 약 38.5%의 CAGR로 매년 성장할 것으로 예상됩니다.

유형별로는 진단이 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

용도별로는 2023년 제2형 당뇨병이 주요 유형으로 부상했습니다.

2023년에는 클라우드 기반이 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 주요 수익원으로 부상했습니다.

당뇨병 관리 분야 인공지능 시장 - 세분화 분석:

당뇨병 관리의 세계 인공지능 시장은 유형, 용도, 전개, 최종사용자 및 지역에 따라 세분화됩니다.

유형별로는 치료 계획, 진단, 진단, 환자 자가 관리, 진단 등 4가지로 분류됩니다. 진단 분야가 시장을 주도하고 있습니다. 이러한 성장은 당뇨병 유병률의 증가와 조기 발견에 대한 중요성이 높아졌기 때문입니다.

이 시장은 임신성 당뇨병, 1형 당뇨병, 제2형 당뇨병의 세 가지 범주로 나뉘며, 제2형 당뇨병 부문이 시장을 지배하고 있으며, 예측 기간 동안 그 우위를 유지할 것으로 보입니다. 이는 1형 당뇨병에 비해 제2형 당뇨병의 유병률이 증가하고 있기 때문입니다.

당뇨병 관리 분야 인공지능 시장 - 지리적 인사이트

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져오는 국가에 따라 더 세분화됩니다.

당뇨병 관리 분야 인공지능 시장 - 경쟁 상황:

정확하고 데이터 중심의 당뇨병 치료를 위한 AI 기반 도구의 채택이 증가함에 따라 세계 시장이 확대되고 있습니다. 이 시장의 기업들은 기존 당뇨병 모니터링 시스템에 AI를 통합하여 실시간 혈당 분석 및 개인화된 추천을 가능하게 하기 위해 의료 서비스 제공자와의 파트너십에 집중하고 있습니다. 또한, 기업들은 고급 AI 알고리즘에 투자하여 예측 능력을 향상시키고 조기 개입과 최적화된 치료 요법을 촉진하여 환자 결과를 개선하기 위해 노력하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 당뇨병 관리 분야 인공지능

경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
기업 개요
- Eli Lilly and Company
- Johnson & Johnson
- Tandem Diabetes Care
- AstraZeneca
- Sanofi
- BD
- Insulet
- Bayer
- Novo Nordisk
- Ypsomed
- Medtronic
- Dexcom
- Merck &Co. Inc.
- Abbott
- Bigfoot Biomedical, Inc.
- Crayon Group
- Cardinal Health Inc.
- DreaMed Diabetes, Ltd.
- Eyenuk, Inc.
- Glooko SAS
- F. Hoffmann-La Roche Ltd.
- HCL Technologies Limited
- Medtronic PLC
- International Business Machines Corporation
- Virta Health Corp.
- Others

제13장 애널리스트의 전방위 전망

ksm 24.12.20

REPORT HIGHLIGHT

Artificial intelligence in diabetes management market size was valued at USD 21,234 Million in 2023, expanding at a CAGR of 38.5% from 2024 to 2032.

Artificial intelligence (AI) in diabetes management uses advanced algorithms and data-driven insights to monitor, predict, and optimize patient care. By analyzing blood glucose patterns, diet, exercise, and lifestyle data, AI systems offer personalized recommendations for medication dosing, dietary adjustments, and activity levels. This technology improves real-time decision-making, enhances glycemic control, and helps healthcare providers deliver proactive, efficient, and patient-specific diabetes management, ultimately reducing complications and promoting healthier outcomes.

Artificial Intelligence in Diabetes Management Market- Market Dynamics

Increasing prevalence of diabetes and technological advancements in AI to propel market demand

The global increase in diabetes cases fuels demand for AI-driven solutions in disease management. In 2021, the International Diabetes Federation reported 537 million adults with diabetes, a figure expected to reach 783 million by 2045. This surge amplifies the need for advanced, AI-enabled diabetes management tools. Besides, improved AI and machine learning capabilities drive the growth of AI in diabetes management market. However, the significant costs of deploying AI systems in healthcare act as a barrier. On the contrary, the global healthcare reforms and government initiatives are supporting AI-driven diabetes care, thereby boosting opportunities for the market.

Artificial Intelligence in Diabetes Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 38.5% over the forecast period (2024-2032)

Based on type segmentation, diagnostics was predicted to show maximum market share in the year 2023

Based on application segmentation, type 2 diabetes was the leading type in 2023

Based on deployment segmentation, cloud-based was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Artificial Intelligence in Diabetes Management Market- Segmentation Analysis:

The Global Artificial Intelligence in Diabetes Management Market is segmented on the basis of Type, Application, Deployment, End User, and Region.

The market is divided into four categories based on type: treatment planning, diagnostics, patient self-management, and diagnostics. The diagnostics sector dominates the market. This growth can be attributed to the the rising prevalence of diabetes and the growing emphasis on early detection.

The market is divided into three categories based on application: gestational diabetes, type 1 diabetes, and type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing prevalence of type 2 diabetes compared to type 1 diabetes.

Artificial Intelligence in Diabetes Management Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Artificial Intelligence in Diabetes Management Market- Competitive Landscape:

The global market is expanding due to increased adoption of AI-driven tools for precise, data-oriented diabetes care. Companies in this market are focusing on partnerships with healthcare providers to integrate AI into existing diabetes monitoring systems, enabling real-time blood glucose analysis and personalized recommendations. Additionally, firms are investing in advanced AI algorithms to enhance predictive capabilities, facilitating early intervention and optimized treatment regimens to improve patient outcomes.

Recent Developments:

In March 2024, Roche introduced the AI-powered diabetes tracker, Accu-Chek SmartGuide, which uses real-time continuous glucose monitoring to predict blood sugar fluctuations up to two hours ahead.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eli Lilly and Company
Johnson & Johnson
Tandem Diabetes Care
AstraZeneca
Sanofi
BD
Insulet
Bayer
Novo Nordisk
Ypsomed
Medtronic
Dexcom
Merck & Co. Inc.
Abbott
Bigfoot Biomedical, Inc.
Crayon Group
Cardinal Health Inc.
DreaMed Diabetes, Ltd.
Eyenuk, Inc.
Glooko SAS
F. Hoffmann-La Roche Ltd.
HCL Technologies Limited
Medtronic PLC
International Business Machines Corporation
Virta Health Corp.
Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Treatment Planning
Data Management
Diagnostics
Patient Self-management

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Gestational Diabetes
Type 1 Diabetes
Type 2 Diabetes

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2019 - 2032

Software as a Service (SaaS)
On-premise
Cloud-based

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Ambulatory Surgical Centers
Hospitals & Clinics
Patients
Diabetes Treatment Centers

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Artificial Intelligence in Diabetes Management Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Artificial Intelligence in Diabetes Management Market Snippet by Type
- 2.1.2. Artificial Intelligence in Diabetes Management Market Snippet by Application
- 2.1.3. Artificial Intelligence in Diabetes Management Market Snippet by Deployment
- 2.1.4. Artificial Intelligence in Diabetes Management Market Snippet by End User
- 2.1.5. Artificial Intelligence in Diabetes Management Market Snippet by Country
- 2.1.6. Artificial Intelligence in Diabetes Management Market Snippet by Region
2.2. Competitive Insights

3. Artificial Intelligence in Diabetes Management Key Market Trends

3.1. Artificial Intelligence in Diabetes Management Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Artificial Intelligence in Diabetes Management Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Artificial Intelligence in Diabetes Management Market Opportunities
3.4. Artificial Intelligence in Diabetes Management Market Future Trends

4. Artificial Intelligence in Diabetes Management Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Diabetes Management Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Artificial Intelligence in Diabetes Management Market Landscape

6.1. Artificial Intelligence in Diabetes Management Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Diabetes Management Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Treatment Planning
- 7.1.3. Data Management
- 7.1.4. Diagnostics
- 7.1.5. Patient Self-management

8. Artificial Intelligence in Diabetes Management Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Gestational Diabetes
- 8.1.3. Type 1 Diabetes
- 8.1.4. Type 2 Diabetes

9. Artificial Intelligence in Diabetes Management Market - By Deployment

9.1. Overview
- 9.1.1. Segment Share Analysis, By Deployment, 2023 & 2032 (%)
- 9.1.2. Software as a Service (SaaS)
- 9.1.3. On-premise
- 9.1.4. Cloud-based

10. Artificial Intelligence in Diabetes Management Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 10.1.2. Ambulatory Surgical Centers
- 10.1.3. Hospitals & Clinics
- 10.1.4. Patients
- 10.1.5. Diabetes Treatment Centers

11. Artificial Intelligence in Diabetes Management Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Artificial Intelligence in Diabetes Management Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Artificial Intelligence in Diabetes Management Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Artificial Intelligence in Diabetes Management Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Artificial Intelligence in Diabetes Management Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Artificial Intelligence in Diabetes Management Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Artificial Intelligence in Diabetes Management Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Eli Lilly and Company
- 12.2.2. Johnson & Johnson
- 12.2.3. Tandem Diabetes Care
- 12.2.4. AstraZeneca
- 12.2.5. Sanofi
- 12.2.6. BD
- 12.2.7. Insulet
- 12.2.8. Bayer
- 12.2.9. Novo Nordisk
- 12.2.10. Ypsomed
- 12.2.11. Medtronic
- 12.2.12. Dexcom
- 12.2.13. Merck & Co. Inc.
- 12.2.14. Abbott
- 12.2.15. Bigfoot Biomedical, Inc.
- 12.2.16. Crayon Group
- 12.2.17. Cardinal Health Inc.
- 12.2.18. DreaMed Diabetes, Ltd.
- 12.2.19. Eyenuk, Inc.
- 12.2.20. Glooko SAS
- 12.2.21. F. Hoffmann-La Roche Ltd.
- 12.2.22. HCL Technologies Limited
- 12.2.23. Medtronic PLC
- 12.2.24. International Business Machines Corporation
- 12.2.25. Virta Health Corp.
- 12.2.26. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us